(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with Idiopathic Parkinson Disease in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (35.14) | 18.2507 |
2000's | 16 (43.24) | 29.6817 |
2010's | 7 (18.92) | 24.3611 |
2020's | 1 (2.70) | 2.80 |
Authors | Studies |
---|---|
Li, X; Li, Y; Mutaerbieke, N; Qin, Y; Yibulayin, A; Zhang, Q; Zhao, X | 1 |
Gong, X; Liang, X; Liu, L; Wang, X; Zhang, W | 1 |
Ding, ZT; Ge, JJ; Huang, SF; Liu, SY; Wang, J; Wang, YX; Wu, JJ; Wu, P; Zhao, J; Zuo, CT | 1 |
Chen, T; Chen, Y; Guo, Z; Wang, R; Xu, B; Zhang, J; Zhu, H | 1 |
Bohnen, NI; Constantine, GM; Gedela, S; Herath, P; Moore, RY | 1 |
Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H | 1 |
Gai, Y; Guo, LH; Jiang, ZH; Qin, GW; Zhao, G; Zheng, XW | 1 |
Farrer, MJ; Hattori, N; Imai, H; Inoue, Y; Ishii, K; Ishiwata, K; Kachergus, JM; Kitagawa, M; Kono, S; Mizoguchi, K; Mizuno, Y; Nishioka, K; Obi, T; Ross, OA; Takanashi, M | 1 |
Cui, XX; Guo, JF; Jiang, H; Lei, LF; Long, ZG; Pan, Q; Shen, L; Song, XW; Tang, BS; Wang, JL; Xia, K; Xiao, B; Yan, XX | 1 |
Futatsubashi, M; Ouchi, Y; Torizuka, T; Yagi, S; Yokokura, M; Yoshihara, Y; Yoshikawa, E | 1 |
Alstrup, AK; Doudet, DJ; Gjedde, A; Høltzermann, M; Jakobsen, S; Landau, AM; Møller, A; Nahimi, A; Simonsen, M; Vang, K; Wegener, G | 1 |
Huang, T; Liang, X; Shi, X; Tang, G; Wang, H; Zhang, X | 1 |
Liu, S; Shen, L; Tian, ZM; Wang, RM; Wieman, J; Yan, Y; Yin, F; Zhao, QJ | 1 |
Chen, JC; Hwang, JJ; Liao, MH; Lin, KJ; Pan, WH; Ting, G; Wey, SP; Yen, TC | 1 |
Andren, PE; Svenningsson, P; Zhang, X | 1 |
Hattori, N; Ida, H; Kono, S; Miyajima, H; Mizuno, Y; Ouchi, Y; Sakamoto, M; Shirakawa, K; Sugiura, T; Suzuki, H; Takahashi, Y; Tomiyama, H | 1 |
Bohnen, NI; Constantine, GM; Gedela, S; Kuwabara, H; Mathis, CA; Moore, RY; Studenski, SA | 1 |
Cepeda, IL; Cornfeldt, ML; Doudet, DJ; Flores, J; O'Kusky, JR | 1 |
Bohnen, NI; Constantine, GM; Kuwabara, H; Mathis, CA; Moore, RY | 1 |
Madras, BK | 1 |
Isacson, O | 1 |
Dannals, RF; Ehlers, MD; Frost, JJ; Ravert, HT; Reich, SG; Rosier, AJ; Smith, JS; Snyder, SH | 1 |
Laihinen, A; Någren, K; Rinne, JO; Rinne, UK; Ruotsalainen, U; Ruottinen, H | 1 |
Byon, C; Elmaleh, DR; Fischman, AJ; Hanson, RN; Liang, AY; Madras, BK; Meltzer, PC; Shoup, TM | 1 |
Ding, YS; Fowler, JS; Gatley, SJ; Volkow, ND; Wang, GJ | 1 |
Brashear, A; Farlow, MR; Hutchins, GD; Mulholland, GK; Siemers, ER; Zheng, QH | 1 |
Bergman, J; Eronen, E; Haaparanta, M; Oikonen, V; Rinne, JO; Ruottinen, H; Solin, O; Sonninen, P | 1 |
Dannals, RF; Frost, JJ; Ilgin, N; Ravert, HT; Reich, SG; Zubieta, J | 1 |
Futatsubashi, M; Iyo, M; Okada, H; Ouchi, Y; Sakamoto, M; Sekine, Y; Yoshikawa, E | 1 |
Brownell, AL; Isacson, O; Jenkins, BG | 1 |
Futatsubashi, M; Kanno, T; Nobezawa, S; Okada, H; Ouchi, Y; Sakamoto, M; Torizuka, T; Yoshikawa, E | 1 |
Berciano, J; Figols, J; González, AM; Pascual, J; Pazos, A | 1 |
Bergman, J; Haaparanta, M; Kaasinen, V; Nurmi, E; Rinne, JO; Ruottinen, HM; Solin, O | 1 |
Bergman, J; Eskola, O; Hinkka, SM; Nurmi, E; Rinne, JO; Solin, O; Sonninen, P | 1 |
Futatsubashi, M; Kanno, T; Nobezawa, S; Okada, H; Ouchi, Y; Tanaka, K; Torizuka, T; Yoshikawa, E | 1 |
Bergman, J; Eskola, O; Nurmi, E; Rinne, OJ; Ruottinen, HM; Solin, O | 1 |
Kaufman, MJ; Madras, BK | 1 |
4 trial(s) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Idiopathic Parkinson Disease
Article | Year |
---|---|
The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study.
Topics: Carbon Radioisotopes; Cocaine; Drug Residues; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography | 2012 |
Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.
Topics: Aged; Aged, 80 and over; Antigens, CD; Bucladesine; Carbon Isotopes; Cell Differentiation; Cells, Cultured; Cocaine; Dopamine Uptake Inhibitors; Female; Fetus; Flow Cytometry; Growth Substances; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Stem Cells; Neurons; Parkinson Disease; Pituitary Adenylate Cyclase-Activating Polypeptide; Positron-Emission Tomography; Retinal Pigment Epithelium; Severity of Illness Index; Time Factors; Treatment Outcome; Tretinoin | 2012 |
Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Topics: Adult; Aged; Antiparkinson Agents; Biological Transport; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
Topics: Aged; Arteries; Blood Pressure; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Frontal Lobe; Gait; Gyrus Cinguli; Heart Rate; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Substantia Nigra; Tomography, Emission-Computed; Walking | 2001 |
33 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Idiopathic Parkinson Disease
Article | Year |
---|---|
Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-β-carbomethoxy-3-β-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease.
Topics: Aged; Basal Ganglia; Brain; Carbon Radioisotopes; Cocaine; Female; Fluorine Radioisotopes; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron Emission Tomography Computed Tomography; Prospective Studies; Severity of Illness Index | 2020 |
Relation between microPET imaging and rotational behavior in a parkinsonian rat model induced by medial forebrain bundle axotomy.
Topics: Animals; Apomorphine; Axotomy; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Functional Laterality; Male; Medial Forebrain Bundle; Parkinson Disease; Raclopride; Radionuclide Imaging; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2014 |
Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
Topics: Adult; Age of Onset; Aged; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Humans; Male; Middle Aged; Neuroimaging; Organ Specificity; Parkinson Disease; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tissue Distribution | 2015 |
Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Humans; Male; Middle Aged; Molecular Imaging; Parkinson Disease; Positron Emission Tomography Computed Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Young Adult | 2017 |
Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
Topics: Aged; Carbon Isotopes; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Hippocampus; Humans; Male; Mental Status Schedule; Middle Aged; Models, Biological; Neural Pathways; Olfaction Disorders; Parkinson Disease; Radionuclide Imaging | 2008 |
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase | 2009 |
In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cocaine; Cricetinae; Cricetulus; Dopamine; Dopamine Agents; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Norepinephrine; Parkinson Disease; Phenols; Psoralea; Rats; Rats, Sprague-Dawley; Synaptosomes; Tyrosine 3-Monooxygenase | 2009 |
Expanding the clinical phenotype of SNCA duplication carriers.
Topics: Adult; Aged; alpha-Synuclein; Brain; Carbon Isotopes; Chromosome Mapping; Cocaine; Family Health; Female; Fluorodeoxyglucose F18; Gene Dosage; Gene Duplication; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Parkinson Disease; Phenotype; Positron-Emission Tomography; Raclopride; REM Sleep Behavior Disorder; Sensory Thresholds; Smell; Young Adult | 2009 |
Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings.
Topics: Adult; Aged; Ataxin-3; Ataxins; Carbon Isotopes; China; Cocaine; DNA Mutational Analysis; Family Health; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Parkinson Disease; Positron-Emission Tomography; Repressor Proteins; Trinucleotide Repeat Expansion | 2009 |
Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET.
Topics: Adult; Aged; Cerebral Cortex; Cocaine; Disease Progression; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis | 2010 |
Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Carbon Isotopes; Cocaine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Female; Functional Laterality; Levodopa; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Serotonergic Neurons; Serotonin Receptor Agonists | 2012 |
Biodistribution study of [99mTc] TRODAT-1 alone or combined with other dopaminergic drugs in mice with macroautoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Cocaine; Dopamine Agents; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred ICR; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tropanes | 2002 |
Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Brain-Derived Neurotrophic Factor; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Administration Schedule; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinson Disease; Protein Binding; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Subthalamic Nucleus; Tritium | 2006 |
Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier.
Topics: Adult; Carbon Radioisotopes; Cocaine; Dopamine; Dopamine Antagonists; Gaucher Disease; Heterozygote; Humans; Male; Neurons; Parkinson Disease; Positron-Emission Tomography; Raclopride | 2007 |
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
Topics: Aged; Cocaine; Corpus Striatum; Denervation; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Substantia Nigra | 2007 |
Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease.
Topics: Analysis of Variance; Animals; Autoradiography; Cell Transplantation; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Uptake Inhibitors; Extremities; Functional Laterality; Humans; Male; Motor Neuron Disease; Parkinson Disease; Pigment Epithelium of Eye; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Time Factors; Transplantation, Heterologous | 2007 |
Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease.
Topics: Aged; Biomarkers; Cocaine; Female; Humans; Isotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Striatonigral Degeneration | 2007 |
11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's disease.
Topics: Carbon Radioisotopes; Cocaine; Dopamine; Humans; Parkinson Disease; Tomography, Emission-Computed | 1994 |
Clinical and preclinical PET correlates of parkinsonism with 11C-WIN 35,428.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbon Radioisotopes; Cocaine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1994 |
Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
Topics: Biomarkers; Brain; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Middle Aged; Nerve Tissue Proteins; Organ Specificity; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1993 |
PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease.
Topics: Adult; Biological Transport; Brain; Carbon Radioisotopes; Cocaine; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Parkinson Disease; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins | 1995 |
Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites.
Topics: Animals; Autoradiography; Brain; Carrier Proteins; Citalopram; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Saimiri; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon | 1996 |
Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Parkinson Disease; Primates; Radioligand Assay; Radiopharmaceuticals; Reference Values; Substance-Related Disorders; Tomography, Emission-Computed | 1998 |
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
Topics: Adult; Aged; Brain Mapping; Carbon Radioisotopes; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Uptake Inhibitors; Dystonia; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed | 1999 |
Striatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson's disease.
Topics: Aged; Animals; Caudate Nucleus; Cocaine; Dopamine Uptake Inhibitors; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1999 |
PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.
Topics: Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1999 |
Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
Topics: Aged; Amygdala; Binding Sites; Brain; Carrier Proteins; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Frontal Lobe; Humans; Kinetics; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Orbit; Parkinson Disease; Radiography; Time Factors; Tomography, Emission-Computed | 1999 |
Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Biomarkers; Cocaine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Haplorhini; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Models, Biological; Parkinson Disease; Tomography, Emission-Computed; Visual Cortex | 1999 |
Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
Topics: Aged; Benzazepines; Brain; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellum; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Functional Laterality; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Receptors, Dopamine D1; Reference Values; Substantia Nigra; Tomography, Emission-Computed | 1999 |
Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration.
Topics: Aged; Autoradiography; Benzamides; Cadaver; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Receptors, Dopamine D2; Reference Values; Striatonigral Degeneration | 2000 |
Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
Topics: Aged; Antiparkinson Agents; Brain; Carrier Proteins; Caudate Nucleus; Cerebellum; Cocaine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Fluorine Radioisotopes; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Time Factors; Tomography, Emission-Computed | 2000 |
[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Topics: Aged; Brain; Caudate Nucleus; Cocaine; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Female; Fluorine Radioisotopes; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Presynaptic Terminals; Putamen; Synaptic Transmission | 2001 |
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
Topics: Aged; Autoradiography; Carrier Proteins; Caudate Nucleus; Cocaine; Corpus Striatum; Humans; Parkinson Disease; Putamen; Receptors, Drug; Reference Values; Tritium | 1991 |